Riskpilot← Back to searchSign inGet full accessDanamedicus AB
ABActiveOrg 5569073736Strandvägen 29General medical practice activities · NACE 8621Est. 20121-4 employees
Revenue 2024
SEK 560K
-65% vs 2023
EBITDA margin
-52.3%
-148% vs 2023
Equity ratio
91.8%
Financial strength
Net profit 2024
SEK 28K
-95% vs 2023
| Revenue | SEK 560K | -65% |
| EBITDA | SEK -293K | -148% |
| Net profit | SEK 28K | -95% |
| Total assets | SEK 1,4M | -36% |
| Equity | SEK 1,3M | -23% |
| Employees | — | — |
Legal name
Danamedicus AB
Org number
5569073736
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
19 oktober 2012
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva uthyrning av läkartjänster, samt därmed förenlig verksamhet.
Address
Strandvägen 29
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 1 299 | 1 279 | 1 664 | 1 529 | 1 307 | 1 548 | 1 595 | 560 |
| Staff expenses | — | — | — | — | — | — | — | — | — | −766 |
| EBITDA | 772 | 463 | 859 | 653 | 729 | 621 | 372 | 530 | 613 | −293 |
| Depreciation & amort. | −8 | −8 | −8 | −6 | −6 | −0 | −0 | −0 | −0 | — |
| EBIT | 764 | 455 | 851 | 647 | 723 | 621 | 372 | 530 | 613 | −293 |
| Net financials | — | 1 | — | 1 | 3 | 3 | 9 | 11 | 34 | 46 |
| Profit before tax | 764 | 455 | 850 | 649 | 725 | 469 | 286 | 411 | 647 | 38 |
| Tax | −168 | −100 | −187 | −143 | −155 | −101 | −59 | −86 | −137 | −10 |
| Net profit | 596 | 355 | 663 | 506 | 570 | 368 | 227 | 325 | 510 | 28 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 909 | 594 | 936 | 1 240 | 1 651 | 1 804 | 1 900 | 2 021 | 2 154 | 1 384 |
| Equity | 745 | 550 | 914 | 1 219 | 1 512 | 1 580 | 1 507 | 1 532 | 1 642 | 1 270 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Short-term debt | 164 | 44 | 22 | 20 | 139 | 69 | 143 | 109 | 132 | 19 |
| Total debt | 164 | 44 | 22 | 20 | 139 | 69 | 143 | 109 | 132 | 19 |
EBITDA margin
-52.3%
This company
15.8%
Market median
-431% vs market
20152024
Equity ratio
91.8%
This company
38.2%
Market median
+140% vs market
20152024
Return on equity
2.2%
This company
18.4%
Market median
-88% vs market
20152024
Net profit margin
5.0%
This company
8.1%
Market median
-38% vs market
20152024
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20152024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
UG Audit | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Danamedicus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulf Gustav Jonsson | Audit | 0 companies |
| Britt Monika Otto | Deputy Board Member | 0 companies |
| Britt Monika Otto | Deputy Board Member | 0 companies |
| Niels Jörgen Otto | Board of Directors | 0 companies |